81 related articles for article (PubMed ID: 22070051)
1. Shattering the underpinnings of neoplastic architecture in LNCap: synergistic potential of nutraceuticals in dampening PDGFR/EGFR signaling and cellular proliferation.
Farooqi AA; Bhatti S; Rana A; Fayyaz S; Mansoor Q; Javed Z; Riaz AM; Nisar K; Ahsan Qu; Dilawar BA; Asif H; Khanum R; Javeed MK
J Exp Ther Oncol; 2011; 9(3):201-6. PubMed ID: 22070051
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.
Pledgie-Tracy A; Sobolewski MD; Davidson NE
Mol Cancer Ther; 2007 Mar; 6(3):1013-21. PubMed ID: 17339367
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells.
Yao H; Wang H; Zhang Z; Jiang BH; Luo J; Shi X
Int J Cancer; 2008 Sep; 123(6):1255-61. PubMed ID: 18561315
[TBL] [Abstract][Full Text] [Related]
6. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
9. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
[TBL] [Abstract][Full Text] [Related]
11. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.
Chen YC; Chang CN; Hsu HC; Chiou SJ; Lee LT; Hseu TH
Life Sci; 2009 Jun; 84(25-26):915-22. PubMed ID: 19393247
[TBL] [Abstract][Full Text] [Related]
12. Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
Hofer MD; Fecko A; Shen R; Setlur SR; Pienta KG; Tomlins SA; Chinnaiyan AM; Rubin MA
Neoplasia; 2004; 6(5):503-12. PubMed ID: 15548358
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
Khor TO; Keum YS; Lin W; Kim JH; Hu R; Shen G; Xu C; Gopalakrishnan A; Reddy B; Zheng X; Conney AH; Kong AN
Cancer Res; 2006 Jan; 66(2):613-21. PubMed ID: 16423986
[TBL] [Abstract][Full Text] [Related]
14. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance.
Fischer T; Najjar A; Totzke F; Schächtele C; Sippl W; Ritter C; Hilgeroth A
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1-8. PubMed ID: 29098884
[TBL] [Abstract][Full Text] [Related]
16. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
[TBL] [Abstract][Full Text] [Related]
17. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
[TBL] [Abstract][Full Text] [Related]
18. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
Lim YC; Cha YY
J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]